Drug Information
| Drug Generic Name | BEZAFIBRATE |
| Drug Class | FIBRATES |
| Chapter | Cardiovascular System |
|
Indications: hypertriglyceridaemia, hypercholesterolemia. Cautions: reduce dose in moderate renal impairment; correct hypothyroidism before initiation of treatment Contra-indications: severe renal or hepatic impairment, hypoalbuminaemina, primary biliary cirrhosis, gall bladder disease, nephrotic syndrome, pregnancy and breast feeding. Side Effects: gastrointestinal disturbance, rash, pruritis, rarely peripheral neuropathy. Dose: 400 mg daily after food (this sustained release dose form is not appropriate in renal impairment). |
|
| Brand Name |
|
